TY  - JOUR

T1  - 549 - Laboratory parameters in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial

JO  - British Journal of Dermatology

UR  - http://dx.doi.org/10.1093/bjd/ljad498.049

PY  - 2024/02/07

AU  - Paller A

AU  - Cork M

AU  - Hong C-H

AU  - Soong W

AU  - Schneider S

AU  - Lo H

AU  - Pedersen LRM

AU  - Vacko E

AU  - Wollenberg A

ED  - 

DO  - DOI: 10.1093/bjd/ljad498.049

PB  - Oxford University Press (OUP)

VL  - 190

IS  - Supplement_2

SP  - ii47

EP  - ii48

Y2  - 2024/12/22

ER  -